Class period: September 14, 2020 - October 9, 2020
Recovered: $27.5 Million
In re Aimmune Therapeutics Securities Litigation, Case No. 20-cv-06733-MMC (NDCA 2020)
Monteverde & Associates PC, as Co-Lead Counsel, has secured a $27.5 million settlement in connection with litigation challenging the acquisition and tender offer of Aimmune Therapeutics, Inc.
SETTLEMENT PENDING COURT APPROVAL